Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy—The BIOCRT Study

BACKGROUND: Cardiac resynchronization therapy (CRT) improves mitral regurgitation (MR) in a subset of patients. We hypothesized that biomarkers (amino-terminal pro-B type natriuretic peptide [NT-proBNP], high-sensitivity troponin [hsTnI], galectin-3 [gal-3] and soluble ST-2 [sST2]) may predict MR re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can J Cardiol
Autors principals: Beaudoin, Jonathan, Singh, Jagmeet P., Szymonifka, Jackie, Zhou, Qing, Levine, Robert A., Januzzi, James L., Truong, Quynh A.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5123954/
https://ncbi.nlm.nih.gov/pubmed/27527259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2016.05.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars